Home Tools
Log in
Cart

Search Result

Search Results for " 1239908-20-3 "

4

Compounds

Cat No. Product Name Synonyms Targets
T8397 Ixazomib citrate MLN9708 Proteasome , Autophagy
Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (IC50 of 3.4 nM ) with potential antineoplastic activity.
T2122 Ixazomib MLN2238 Proteasome , Caspase , Autophagy
Ixazomib (MLN2238) , a second generation, boron-containing peptide proteasome inhibitor (PI), inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome (IC50/Ki: 3.4/0.93 nM, in cell-free assays), also i...
T69983 Ixazomib citrate EtOH
Ixazomib citrate, also known as MLN9708, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrol...
T2016 MLN9708 Ixazomib Citrate Proteasome
MLN2238 suppresses the chymotrypsin-like proteolytic (β5) site of the 20S proteasome(Ki50=0.93 nM, IC50=3.4 nM/). The biologically active form of MLN9708 (Ixazomib Citrate) is MLN2238 in aqueous solutions or plasma.
TargetMol